PharmaRoth Labs, Inc.
ROTH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.51K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3,512.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 1.83 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About PharmaRoth Labs, Inc.
0CEO: Luis Manuel Ornelas Lopez
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Indust...